| |
| |
|
| Insider
Information: |
Doberstein Stephen K |
| Relationship: |
Director |
| City: |
San Carlos |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
107,668 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$188,957 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
107,668 |
|
|
| Total
Value |
$188,957 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nektar Therapeutics |
NKTR |
SVP & Chief Scientific... |
2019-09-05 |
107,668 |
2016-02-16 |
0 |
Premium* |
|
|
Dicerna Pharmaceuticals Inc |
DRNA |
Director |
2021-12-28 |
0 |
2021-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
40 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2016-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
875 |
875 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2016-02-17 |
4 |
S |
$11.92 |
$4,649 |
D/D |
(390) |
485 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2016-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
875 |
1,360 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2016-05-17 |
4 |
S |
$13.58 |
$4,604 |
D/D |
(339) |
1,021 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2016-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10,500 |
11,521 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2016-08-16 |
4 |
S |
$17.56 |
$23,460 |
D/D |
(1,336) |
18,935 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2016-11-16 |
4 |
S |
$13.96 |
$9,353 |
D/D |
(670) |
18,265 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2016-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
35,765 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-02-16 |
4 |
S |
$13.14 |
$16,570 |
D/D |
(1,261) |
34,504 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-04-05 |
4 |
AS |
$21.70 |
$2,170,000 |
D/D |
(100,000) |
34,504 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-04-05 |
4 |
OE |
$9.53 |
$953,000 |
D/D |
100,000 |
134,504 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-05-16 |
4 |
S |
$19.55 |
$33,255 |
D/D |
(1,701) |
32,803 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-08-16 |
4 |
S |
$19.32 |
$32,863 |
D/D |
(1,701) |
31,102 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-10-05 |
4 |
OE |
$9.53 |
$416,242 |
D/D |
43,677 |
74,779 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-10-05 |
4 |
AS |
$24.97 |
$1,090,615 |
D/D |
(43,677) |
31,102 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-11-06 |
4 |
AS |
$24.98 |
$522,432 |
D/D |
(20,914) |
31,102 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-11-06 |
4 |
OE |
$9.53 |
$199,310 |
D/D |
20,914 |
52,016 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-11-07 |
4 |
OE |
$9.53 |
$718,648 |
D/D |
75,409 |
106,511 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-11-07 |
4 |
AS |
$25.78 |
$1,944,044 |
D/D |
(75,409) |
31,102 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-11-08 |
4 |
AS |
$30.09 |
$9,027,000 |
D/D |
(300,000) |
31,102 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-11-08 |
4 |
OE |
$9.53 |
$2,859,000 |
D/D |
300,000 |
331,102 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
48,602 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-11-16 |
4 |
D |
$44.23 |
$211,508 |
D/D |
(4,782) |
43,820 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2017-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
26,000 |
69,820 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Scientific Officer |
• – – |
2018-02-16 |
4 |
S |
$82.94 |
$201,212 |
D/D |
(2,426) |
67,394 |
0 |
- |
|
40 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
